We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
From the Centers for Disease Control and Prevention |

Hantavirus Pulmonary Syndrome—Five States, 2006 FREE

JAMA. 2006;296(20):2434. doi:10.1001/jama.296.20.2434.
Text Size: A A A
Published online

MMWR. 2006;55:627-629

2 figures omitted

Hantavirus pulmonary syndrome (HPS) is a rodentborne viral disease characterized by severe pulmonary illness and a case-fatality ratio of 30%-40%. Sin Nombre virus causes the majority of HPS cases in the United States, and the deer mouse (Peromyscus maniculatus) is its predominant reservoir. This report describes an increase in human cases of HPS reported during January-March 2006 from Arizona, New Mexico, North Dakota, Texas, and Washington state. The findings emphasize the need for renewed attention to reducing the risk for hantavirus exposure.

Human HPS

HPS is characterized by a febrile illness (i.e., temperature >101.0°F) associated with bilateral diffuse interstitial edema of the lungs developing within 72 hours of hospitalization in a previously healthy person; radiographically, the edema can resemble acute respiratory distress syndrome.1 Annually, the majority of HPS cases occur in spring and summer; however, the seasonality of HPS can vary by elevation, location, and biome, and cases have been identified throughout the winter and early spring.2 Since recognition of the disease in 1993, CDC has confirmed 438 cases of HPS* reported from 30 states among residents of 32 states; 35% (154) of these cases were fatal.

During January-March 2006, a total of nine confirmed cases (based on onset date) of HPS were reported from Arizona, New Mexico, North Dakota, Texas, and Washington. Six of the nine cases were in Arizona and New Mexico. During 1994 and 1999, a similar number of HPS cases was confirmed nationally in the same 3-month period. Both years were characterized by environmental conditions (e.g., increased rainfall and vegetative biomass) during the preceding 1-2 years that promoted increased rodent populations. This, in turn, increased virus transmission in the rodent populations and increased exposure risk for humans.2-4 During 1994, 1999, and 2000, more than six cases were confirmed in the first 3 months of each year, and all had a high yearly total of HPS cases. Nine cases of HPS were identified in the first 3 months of 2006, suggesting that a greater risk for human hantavirus infection might exist this year.

Reported by:

D Engelthaler, C Levy, Arizona Dept of Health Svcs. P Ettestad, DVM, New Mexico Dept of Health. K Kruger, North Dakota Dept of Health. J Schuermann, Texas Dept of State Health Svcs. M Leslie, DVM, Washington Dept of Health. Special Pathogens Br, Div of Viral and Rickettsial Diseases, National Center for Zoonotic, Vector-Borne, and Enteric Diseases (proposed), CDC.

CDC Editorial Note:

Hantavirus infection can occur after exposure to infectious virus in rodent saliva or excreta. HPS typically begins as headache, fever, and myalgia and is soon followed by pulmonary edema, which often leads to severe respiratory compromise; thrombocytopenia, presence of immunoblasts, and hemoconcentration are characteristic laboratory findings.1 Other than supportive care, no treatment exists for hantavirus infection. The probability of surviving HPS increases with early recognition, hospitalization, and aggressive pulmonary and hemodynamic support.5,6 All health-care providers are strongly encouraged to become familiar with the signs and symptoms of HPS7 and to report suspected cases immediately to their state health departments.

Since 1994, CDC has sponsored continuous monitoring of rodent populations at study sites in Arizona, Colorado, New Mexico, and Montana.8 Larger rodent populations and subsequent higher prevalence of hantavirus infection in rodent populations have been associated with higher risk for hantavirus exposure in human populations.2,9,10 Environmental conditions, including increased rainfall during 2005, likely contributed to increased rodent populations in certain areas of the Southwest. Some rodent monitoring sites have continued to have high rodent population densities or high levels of hantavirus infection during spring 2006, suggesting an increased risk for hantavirus infection among human populations in certain rural areas (J Mills, PhD, personal communication, May 2006).

Public health education (especially among residents of rural areas of the western United States) regarding the importance of risk-reduction measures should be emphasized, especially in spring and summer, when the majority of previous HPS cases have been identified. Most persons with HPS are thought to have been infected in and around their homes; therefore, limiting opportunities for peridomestic exposure to rodents and their excreta is particularly important.

CDC's Seal Up! Trap Up! Clean Up! campaign offers detailed information on preventing transmission of diseases from rodents and a comprehensive rodent-control website.† Measures to prevent HPS include (1) sealing up holes inside and outside the home to prevent entry by rodents, (2) trapping rodents around the home to help reduce the rodent population, (3) cleaning up potential rodent food sources and nesting sites, and (4) taking precautions when cleaning. CDC also provides detailed recommendations for HPS risk reduction.10 Additional information regarding HPS is available from local or state health departments; through the hantavirus hotline, 404-639-1510; on CDC's All About Hantaviruses website‡; and by mail.§

REFERENCES: 10 available.

*As of May 10, 2006.

†Available at http://www.cdc.gov/rodents.

§Special Pathogens Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Mailstop G-14, 1600 Clifton Road, N.E., Atlanta, GA 30333.




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Original Article: Does This Dyspneic Patient in the Emergency Department Have Congestive Heart Failure?

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Original Article: Does This Patient Have Ventilator-Associated Pneumonia?